Received Mar 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (JANSSEN)) | JANSSEN | UNK | — | — |
I will never be the same after the different shots; Revaccination with different covid-19 vaccine; This spontaneous report received from a patient by a business partner (Pfizer Inc.) on 05-Feb-2025 was received by Johnson and Johnson Innovative Medicine on 05-Feb-2025 and concerned a patient of unspecified age and sex. The patient's height and weight were not reported. Age at time of vaccination was unknown. No past medical history, concurrent conditions or pre-existing medical conditions were reported. The patient was previously treated with bnt162b2 and experienced feeling abnormal. The patient received janssen covid-19 vaccine (suspension for injection, route of admin not reported, batch number not reported) dose, frequency and therapy dates not reported, additional dosage information included: dose number series 2, for covid-19 prophylaxis.The batch number was not reported. The company is unable to perform follow-up to request for batch or lot number. No concomitant medications were reported. On an unspecified date, the patient experienced i will never be the same after the different shots and revaccination with different covid-19 vaccine. (dose number series 2). Patient reported that they got that shot and the jj before the 2nd shots and will never be the same after the different shots The action taken with janssen covid-19 vaccine was not applicable. The outcome of i will never be the same after the different shots and revaccination with different covid-19 vaccine was not reported. This report was non-serious.